Prestige Consumer Healthcare PBH Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current)?
- Prestige Consumer Healthcare (PBH) reported allowance for doubtful accounts receivable (current) of $21.09M in Q4 2025.
- How has Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current) changed year-over-year?
- Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current) increased by 26.5% year-over-year, from $16.67M to $21.09M.
- What is the long-term trend for Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current)?
- Over 4 years (2021 to 2025), Prestige Consumer Healthcare's allowance for doubtful accounts receivable (current) has grown at a -0.2% compound annual growth rate (CAGR), from $16.46M to $16.31M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.